Intrinsic Value of S&P & Nasdaq Contact Us

CordovaCann Corp. LVRLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
9/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

CordovaCann Corp. (LVRLF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.04. It has a SharesGrow Score of 9/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $14M, +1.8%/yr average growth. Net income is $3M (loss), growing at -32.2%/yr. Net profit margin is -21% (negative). Gross margin is 10.9% (-16.7 pp trend).

Balance sheet: total debt is $5M with negative equity of -$6M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.19 (tight liquidity). Debt-to-assets is 78%. Total assets: $6M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 30/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 7/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

LVRLF SharesGrow Score Overview

16/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 7/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.002-0.121
Volume28K
Avg Volume (30D)4.37K
Market Cap$3.84M
Beta (1Y)-0.80
Share Statistics
Shares Outstanding$109.78M
IPO Date2018-03-27
CEOThomas Turner Jr.
Financial Highlights & Ratios
Revenue (TTM)$14.26M
Gross Profit$1.56M
EBITDA$-1M
Net Income$-3M
Total Cash$598.62K
Total Debt$5M
Net Debt$4.4M
Total Assets$6.41M
Price / Sales (P/S)0.27
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA21864T1075

Price Chart

LVRLF
CordovaCann Corp.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.12
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message